Back to Top Vancomycin-resistant Enterococci (VRE) | The Ottawa Hospital Favourite Icon
 

VRE stands for vancomycin-resistant enterococcus. Vancomycin is an antibiotic used to treat infections. Enterococcus is a common bacterium that is normally found in the lower intestine. Sometimes people develop infections with this bacterium and require treatment. Only a few antibiotics can effectively treat enterococcal infections, and one of them is vancomycin. If the enterococcus bacterium develops resistance to vancomycin (vancomycin-resistant enterococcus), the antibiotic vancomycin will not be able to destroy the bacteria. There are other antibiotics that will treat VRE infections.

VRE Bacteremia Nosocomial Cases

VRE Bacteremia Nosocomial Cases
Civic Campus General Campus The Rehabilitation Centre
Quarterly Nosoc. Cases *Pt Days Incidence per 1000  Pt days Nosoc. Cases *Pt Days Incidence per 1000  Pt days Nosoc. Cases *Pt Days Incidence per 1000  Pt days
Fiscal Year 2018 – 2019
Q1 – Apr to Jun < 5 42,338 0.07 6 49,212 0.12 0 5,977 0.00
Q2 – Jul to Sep 0 40,725 0.00 8 49,991 0.16 0 5,906 0.00
Q3 – Oct to Dec <5 42,666 0.09 9 51,285 0.18 0 5,904 0.00
Q4 – Jan to Mar <5 44,468 0.09 5 50,309 0.10 0 5,857 0.00
Fiscal Year 2017 – 2018
Q1 – Apr to Jun < 5 41,253 0.05 6 49,080 0.12 0 4,559 0.00
Q2 – Jul to Sep 0 40,725 0.00 8 49,991 0.16 0 5,906 0.00
Q3 – Oct to Dec <5 42,666 0.09 9 51,285 0.18 0 5,904 0.00
Q4 – Jan to Mar 5 43,183 0.12 9 51,429 0.17 0 5,800 0.00
Fiscal Year 2016 – 2017
Q1 – Apr to Jun < 5 39,262 0.10 5 49,908 0.10 0 4,559 0.00
Q2 – Jul to Sep 0 41,105 0.00 6 50,217 0.12 0 4,455 0.00
Q3 – Oct to Dec < 5 40,568 0.05 10 50,717 0.20 0 4,764 0.00
Q4 – Jan to Mar < 5 42,784 0.02 6 50,816 0.12 0 5,076 0.00
Fiscal Year 2015 – 2016
Q1 – Apr to Jun < 5 39,165 0.03 0 48,484 0.00 0 4,743 0.00
Q2 – Jul to Sep 0 39,527 0.00 < 5 49,107 0.02 0 4,476 0.00
Q3 – Oct to Dec 0 39,760 0.00 0 48,524 0.00 0 4,314 0.00
Q4 – Jan to Mar 5 40,255 0.12 < 5 50,316 0.04 0 4,507 0.00
Fiscal Year 2014 – 2015
Q1 – Apr to Jun 0 38,452 0.00 < 5 46,333 0.06 0 4,653 0.00
Q2 – Jul to Sep 0 37,520 0.00 < 5 46,913 0.02 0 4,637 0.00
Q3 – Oct to Dec 0 37,644 0.00 0 47,828 0.00 0 4,871 0.00
Q4 – Jan to Mar 0 37,434 0.00 < 5 48,302 0.04 0 4,805 0.00
Fiscal Year 2013 – 2014
Q1 – Apr to Jun 0 36,214 0.00 < 5 45,433 0.04 0 4,897 0.00
Q2 – Jul to Sep 0 36,605 0.00 < 5 43,974 0.05 0 4,616 0.00
Q3 – Oct to Dec 0 38,209 0.00 < 5 47,237 0.08 0 4,718 0.00
Q4 – Jan to Mar 0 38,218 0.00 < 5 46,780 0.04 0 4,815 0.00